PRESIDENT'S MESSAGE Dear Fellow Pathologists:
This is the first issue of your $Bulletin. The emphasis is on &dquo;your&dquo; because the Bulletin is for the members of the Society of Pharmacological and Environmental Pathologists and can only continue with your help and contributions.
It is appropriate to review the accomplishments of the Society, since I issued a Newsletter in February of 1972 and to thank the colleagues who have helped progress.
Firstly, I would like to thank the editor of the Bulletin, Dr. Marcus M. Mason and Dr. J.R.M.
Innes, for the splended job they have done in preparing the publication. The Newsletter will continue as a news media for the Executive Committee and will be published when needed.
On 12 May 1972, the Internal Revenue Service informed me that the Society of Pharmacological and Environmental Pathologists is exempted from federal income tax which is the most important event of the last six months. We are now able to solicit funds for our various objectives and activities.
The nine committees (page 5), which have been in existence since February 1972, have all done a fine job and have accomplished their objectives. I thank the chairmen and their committee members for their efforts.
One committee deserves special mention, since it reflects one of the most important activities of our society, i.e., the Control Data Sharing Committee (see Dr. S.W. Thompson, this page). The art and science of drug safety evaluations have become more and more complex and sophisticated and place a great responsibility on everyone involved. The pooling and sharing of control data which means the establishment of a registry of naturallyoccurring diseases in laboratory animals (e.g., rodents, cats, dogs, monkeys and others), will help to put our evaluation upon a sounder basis and to make our data more meaningful. While it is comparatively easy to design a program to this effect, it is obviously more difficult to persuade individual pathologists to abandon some of their &dquo;favorite&dquo; terms for a unified terminology and coding system. This will require a few compromises but I hope that most pathologists will be prepared to make them.
Finally, I thank those colleagues who, as members of the original Discussion Group of Industrial Pathologists, have faithfully participated in the bimonthly meetings of 1970 and 1971. They have demonstrated that it is possible for pathologists, from different pharmaceutical houses, to get together and discuss scientific and logistical problems without jeopardizing company interests. I take this as a good omen and sincerely hope that the Society of Pharmacological and Environmental Pathologists will continue to grow on those principles. Mawdesley-Thomas (England). I nitial ly, the committee made some of statistical studies to ascertain the nature of the problems inherent in the analysis of pathologic data such as (but not limited to) the probability of obtaining true information by subsampling of a given population of experimentally-treated or control animals and the probability of obtaining true information by comparing subsampled populations versus a treated group of animals. The results of the studies were presented by the Chairman to the members of the Northeastern Regional Discussion Group of the S.P.E.P. at the Ortho Research Foundation, Raritan, New Jersey on 24 March 72 and to the Scientific Session of a symposium sponsored by the Delaware Valley and Metropolitan New York Branches of AALAS at East Brunswick, New Jersey on 1 June 1972.
The Committee concluded that subsampling was an unacceptable means of evaluating the lesion incidence within any sharply-defined population of limited numbers of animals, including control animals. The data supplied by each participant in a control-data-sharing program must not be derived from subsamples of the total defined population of control animals for a given experiment. The Committee also concluded that the random distribution of animals within an experiment does not preclude the fortuitous accumulation of a pre-existent abnormality in 1 group to the exclusion of any 1 of 3 other groups (10 animals per group) in sufficient numbers to be significant (p=0.5) when compared with the group in which the lowest incidence of the same abnormality occurred. The obvious advantage would be to have a large pool of control data (N-pool) of such magnitude that the true incidence of the spontaneous abnormality is known within the range of 95% confidence limits for the age, sex, species, and strain of the animal under test.
The Committee met on 21 March 1972 and adopted a coding, data input, retrieval and analysis system for pathology based upon a modification of an existent proven system. At present, the Committee is negotiating for the right to utilize this system for implementation of a Control Data Sharing Program for S.P.E.P. Upon completion of negotiations the Committee will prepare a detailed report to the members to discover the institutions which desire to participate in the program. We also need information to develop cost figures with data processing firms prior to the selection of one to handle the automatic data processing phases.
It is envisioned that the program would function along the following lines: (1) The program would be funded by the Executive Committee by an annual grant to the Control Data Sharing Committee ; (2) participating institutions would enter into a formal, nonfinancial, contract with the Committee to supply their currently developed control data to the program; (3) participants would code their control data according to the anatomic and pathologic codes furnished by the Committee on forms provided according to a series of administrative procedures promulgated by the Committee; (4) the completed data input forms, and supporting specimens, would be forwarded by each participant to the Committee which, in turn, would review the submissions for compliance with the administrative procedures which govern the program; (5) the data would be prepared for addition to the N-pool master file and subjected to a variety of verification procedures; (6) subsequent to verification, the data would be added to the master file of the N-pool; (7) at prescribed intervals each participant would receive an analysis printout which would provide the incidence of all coded abnormalities for each species in the Control Data Bank, subdivided by various parameters such as sex, age, strain and environment, and organized into formats which provide (a) true incidence, (b) 95% confidence limits for each type of abnormality and (c) correlations between the occurrence of certain types of multiple abnormalities within the same animal. From the data provided in such printouts, the individual participants would be able to express the results of their own experiments in a term of reference which would encompass whether, or not, any given abnormality incidence encountered in the study, in each control or treatment group, deviated from that of the N-pool, whether or not the total incidence of each abnorma lity in all test groups exceeded the norm for the study.
To preclude a paucity of cooperation in the form of input into the Control Data Sharing Program, availability of the analyses printouts of the N-pool would be initially limited to participants who have signed formal agreements with the Committee. Without such enforcement to guarantee data input it is feared that there would be nothing to analyze and report. However, the enrollment of participants would not be restrictive and institutions, which had relatively small amounts of data to contribute, would not be discriminated against provided they reported their acceptable data. Present concepts in this regard can be characterized as &dquo;no-input-no-output&dquo;. Financial support of the program would be derived from contributions to S.P.E.P. rather than the Committee per set. It is envisioned that financial support would not be linked with eligibility to become a participant within the program. However, it is apparent that, if those institutions which can provide financial support to S.P.E.P. do not contribute there will be no funds available for the proposed Control Data Sharing Program. This remains the major unresolved problem of the Committee and the Society as a whole.
PHARMACOLOGIC PATHOLOGY

J. R. M. Innes
The phrasing is a trifle anachronistic, if given serious reflection, but it was considered impossible to do better and by common usage no doubt will be acceptable. Pharmacology comes from Greek
